Leinco Technologies

Leinco Technologies is a leading biotechnology company dedicated to advancing scientific discovery through high-quality, reproducible products and custom services. With over 30 years of experience, Leinco Technologies collaborates closely with companies to deliver exceptional results. Located at Primary: 410 Axminister Drive, Fenton, MO 63026, US, Leinco Technologies provides a comprehensive suite of CDMO services, from antibody scale-up and purification to advanced conjugation and assay development, streamlining workflows and accelerating research.

Leinco Technologies' products are optimized for a wide range of applications, including spatial biology, flow cytometry, in vivo studies, and in vitro assays. By employing advanced production techniques, Leinco Technologies ensures the purest monoclonal, recombinant, and polyclonal antibodies and proteins, providing researchers with high-purity reagents for consistent and reproducible results. Leinco Technologies adheres strictly to ISO 9001:2015 and ISO 13485:2016 standards, ensuring that every antibody and protein meets rigorous performance and reliability benchmarks.

Leinco Technologies is committed to quality and innovation in the biotechnology sector. The company’s consultative approach and dedication to excellence make it a trusted partner for companies seeking to drive scientific breakthroughs. We invite the manager of Leinco Technologies to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and reach in the market.